TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills....
SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer,...
EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
SOUTH PLAINFIELD, N.J. , Dec. 13, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 9, 2019 it approved non-statutory stock options to purchase an aggregate...
WASHINGTON (AP) — U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months...
KAPURTHALA, India (AP) — Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists.
LEXINGTON, Mass. , Dec. 13, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. (TSE: 4502) (NYSE:TAK) ("Takeda") and MiTest Health LLC ("MiTest"), a pioneering health technology company, today...
MARLBOROUGH, Mass. , Dec. 13, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT™ Model D Single-Use...
Scientists who’ve studied the curious chemistry of the opioid tramadol use an array of adjectives to describe it: “unpredictable,” “messy,” “crazy.”
CANTON, Conn. , Dec. 13, 2019 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, released today financial performance for the third quarter of 2019.
ABBOTT PARK, Ill., Dec. 13, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 36 cents per share – a 12.5% increase....
GOTHENBURG, Sweden , Dec. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announces the approval from the United States Patent and Trademark Office...
INCLINE VILLAGE, Nev. , Dec. 13, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate, privately negotiated exchange...
SAN DIEGO and PENNINGTON, N.J. , Dec. 13, 2019 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today...
MARLBOROUGH, Mass. , Dec. 13, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary...
RIDGEFIELD , Conn. and INDIANAPOLIS , Dec. 13, 2019 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today results from the EMPERIAL-Reduced and EMPERIAL-Preserved...
SAN DIEGO , Dec. 13, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD) (the "Company"), a medical device technology company focused on developing products to diagnose and treat life and...
INDIANAPOLIS , Dec. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued...
SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today...
